|
2025
|
Invention
|
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof.
There are provided... |
|
|
Invention
|
Bifunctional compound and use thereof. The present disclosure relates to a bifunctional compound ... |
|
|
Invention
|
Bifunctional compounds and uses thereof.
The disclosure relates to bifunctional compounds with a... |
|
|
Invention
|
Glucosamine derivatives and pharmaceutical uses thereof.
There are provided compounds of Formula... |
|
|
Invention
|
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular ... |
|
|
Invention
|
Glucosamine derivative-containing composition, and preparation method therefor and use thereof. A... |
|
|
Invention
|
Salt of kras g12d degradation agent, and preparation method therefor and use thereof. The present... |
|
|
Invention
|
Method for preparing glucosamine derivative. The present disclosure relates to a method for prepa... |
|
|
Invention
|
Bifunctional compound and use thereof. The present invention relates to a bifunctional Kras modul... |
|
2024
|
Invention
|
Crystalline form of 3- ((l-valyl) amino) -i-propanesulfonic acid.
The present invention related ... |
|
|
Invention
|
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof. 3H (I)
|
|
2023
|
Invention
|
Phosphonate compound and medical use thereof. A phosphonate compound or a pharmaceutically accept... |
|
|
Invention
|
Nucleoside analogue and medical application thereof. A nucleoside analog, or a pharmaceutically a... |
|
|
Invention
|
Stable heavy isotopes in amide functional groups and uses thereof. There are provided isotope-enr... |
|
|
Invention
|
Bifunctional compounds and pharmaceutical uses thereof.
The disclosure relates to bifunctional K... |
|
|
Invention
|
Kras inhibitors and pharmaceutical uses thereof.
The disclosure relates to KRAS inhibitor compou... |
|
|
Invention
|
Bifunctional compounds and pharmaceutical uses thereof |
|
|
Invention
|
Kras inhibitors and pharmaceutical uses thereof. The disclosure relates to KRAS inhibitor compoun... |
|
|
Invention
|
Bifunctional compounds and pharmaceutical uses thereof. The disclosure relates to bifunctional KR... |
|
|
Invention
|
Kras inhibitor and pharmaceutical uses thereof.
The disclosure relates to KRASG12D inhibitor com... |
|
|
Invention
|
4-(3,8-diazabicyclo[3.2.1]octan-3-yl)pyrido[4,3-d]pyrimidines and use thereof as kras inhibitors.... |
|
|
Invention
|
Compound for preventing or treating canine bone or joint diseases, composition, and use. The pres... |
|
|
Invention
|
Glucosamine derivatives for the prevention or treatment of joint disorders. There are provided co... |
|
|
Invention
|
Cdk inhibitors and pharmaceutical uses thereof.
The disclosure relates to bifunctional CDK-modul... |
|
|
Invention
|
Cdk inhibitors and pharmaceutical uses thereof. The disclosure relates to bifunctional CDK-modula... |
|
|
Invention
|
Glucosamine derivatives and pharmaceutical uses thereof. There are provided compounds of Formula ... |
|
2022
|
Invention
|
Cd73 inhibitors and pharmaceutical uses thereof. CD73 (also known as ecto-5′-nucleotidase) inhibi... |
|
|
Invention
|
Bivalent compounds, conjugates and uses thereof. There are provided conjugates of Formula (V) whe... |
|
|
Invention
|
Crystal forms of glucosamine derivative, and preparation method therefor and use thereof.
The pr... |
|
|
Invention
|
Crystal forms of glucosamine derivative, and preparation method therefor and use thereof. The pre... |
|
2021
|
Invention
|
Prodrugs of a cdk inhibitor for treating cancers. There are provided compounds of Formula I, and ... |
|
|
Invention
|
Pharmaceutical application of fused ring phenolic compounds.
The present application relates to ... |
|
|
Invention
|
Pharmaceutical application of fused-ring phenolic compound. A fused-ring phenolic compound, or a ... |
|
|
Invention
|
Pharmaceutical application of fused ring phenolic compound. A fused-ring phenolic compound, or a ... |
|
|
Invention
|
Cd73 inhibitors and pharmaceutical uses thereof.
CD73 (also known as ecto-5′-nucleotidase) inhib... |
|
|
Invention
|
Cd73 inhibitors and pharmaceutical uses thereof. CD73 (also known as ecto-5?-nucleotidase) inhibi... |
|
|
Invention
|
Cd73 inhibitors and pharmaceutical uses thereof. CD73 (also known as ecto-5´-nucleotidase) inhibi... |
|
|
Invention
|
Crystalline form of 3-((l-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation met... |
|
2019
|
Invention
|
Crystalline form of 3-((l-valyl) amino)-1-propanesulfonic acid. The present invention relates to ... |
